Surface modifications for titanium, a material of choice for dental implants, can greatly alter the surface micro/nanotopography and composition of implants, leading to notable enhancements in their hydrophilicity, mechanical properties, osseointegration performance, and antibacterial performance, as well as their impacts on osteoblast activity and bone formation processes. This article aims to update titanium surface modification techniques for dental implants from the past to the present, along with their effects on osteoblasts and bone formation, by thoroughly summarizing findings from published studies. Peer-reviewed articles published in English consisting of in vitro, in vivo, and clinical studies on titanium dental implant surface treatments were searched in Google Scholar, PubMed/MEDLINE, ScienceDirect, and the Scopus databases from January 1983 to December 2023 and included in this review. The previous studies show that implant surface roughness, condition, and hydrophilicity are crucial for osteoblast adhesion and growth. While various techniques enhance osseointegration comparably, one of the most common approaches to accomplishing these properties is sandblasting large-grit acid etching surface treatment and coating with hydroxyapatite or chitosan. In conclusion, this review points out the efficacy of different subtraction and addition techniques in enhancing the surface properties of titanium dental implants, promoting favorable outcomes in terms of osteoblast activity and bone formation in various degrees. However, most existing studies predominantly compare treated and non-treated titanium, revealing a need for more comprehensive studies comparing the effects of various modification techniques. Moreover, further investigation of factors playing a role in the dynamic osseointegration process in addition to osteoblasts and their functions, as well as improved surface modification techniques for the treatment of compromised patients, is greatly required.

Customized healing abutments have been introduced in clinical practice along with implant surgery to preserve or create natural-appearing hard and soft tissue around the implant. This provides the benefits of reducing the overall treatment time by eliminating the second stage and reducing the elapsed time of the fabrication of the final prostheses. This article aims to review the types and properties of materials used for the fabrication of customized healing abutments and their clinical applications. Articles published in English on customized healing abutments were searched in Google Scholar, PubMed/MEDLINE, ScienceDirect, and the Scopus databases up to August 2022. The relevant articles were selected and included in this literature review. Customized healing abutments can be fabricated from materials available for dental implants, including PEEK, PMMA, zirconia, resin composite, and titanium. All the materials can be used following both immediate and delayed implant placement. Each material provides different mechanical and biological properties that influence the peri-implant tissues. In conclusion, the studies have demonstrated promising outcomes for all the materials. However, further investigation comparing the effects of each material on peri-implant soft and hard tissues is required.

Gold nanoparticles (AuNPs) have gained significant attention in the biomedical field owing to their versatile properties. AuNPs can be customized by modifying their size, shape and surface characteristics. In recent years, extensive research has explored the integration of AuNPs into various dental materials, including titanium, polymethylmethacrylate (PMMA) and resin composites. This review aims to summarize the advancements in the application of modified AuNPs in dental materials and to assess their effects on related cellular processes in the dental field. Relevant articles published in English on AuNPs in association with dental materials were identified through a systematic search of the PubMed/MEDLINE, Embase, Scopus and ScienceDirect databases from January 2014 to April 2024. Future prospects for the utilization of AuNPs in the field of dentistry are surveyed.

Background: Resin-bonded fixed dental prostheses (RBFDPs) have become an increasingly popular minimally invasive solution for replacing missing anterior teeth. However, their long-term success is influenced by factors such as bridge design and material selection. Methods: This systematic review and meta-analysis aimed to assess the impact of different bridge designs on the clinical performance and failure risks of anterior ceramic RBFDPs. A comprehensive search of electronic databases was conducted to identify clinical studies published in English up to January 2025. Nine studies, including randomized controlled trials, cohort studies, and clinical trials, met the inclusion criteria. Results: The analysis revealed that single-retainer RBFDPs demonstrated lower failure rates than two-retainer models (RR: 0.36, 95% CI: 0.17–0.75). Among failure types, fractures were significantly less common in cantilever designs compared to two-retainer designs (RR: 0.25, 95% CI: 0.09–0.73), while no significant differences were observed in debonding rates (OR: 0.40, 95% CI: 0.015–1.10). Conclusions: In terms of material selection, all-ceramic RBFDPs in cantilever designs exhibited significantly lower failure rates (RR: 0.12, 95% CI: 0.03–0.43), whereas metal-ceramic RBFDPs showed no significant difference in failure rates based on bridge design (RR: 0.56, 95% CI: 0.21–1.53). These findings suggest that all-ceramic cantilever RBFDPs may offer superior long-term outcomes, highlighting the importance of precise preparation and cementation protocols for clinical success.

Background/Objectives: Dental implant placement protocols including immediate (IIP) and delayed implant placement (DIP) are likely to affect bone tissue repair and regeneration after the surgery. Despite many benefits of IIP, it has remained unclear whether IIP demonstrates comparable healing processes and outcomes to those observed in DIP. This review aims to summarize and compare biological and clinical outcomes of IIP and DIP, focusing on success and survival rates, periodontal status, esthetics and radiographic outcomes, and biochemical markers. Methods: A literature search of electronic databases was conducted using PubMed/MEDLINE, Embase, and the Scopus databases (January 1983–February 2025). 109 articles published in English, consisting of in vitro, in vivo, and clinical studies met the inclusion criteria. Results: This review shows that both IIP and DIP show similar implant survival rates, but IIP may lead to a higher risk of mid-facial recession in esthetic areas. DIP, on the other hand, can result in better soft tissue and bone healing. Histological and radiographic evidence shows comparable bone to implant contact (BIC) between the two methods, although peri-implant bone loss tends to be higher with IIP. Lastly, although specific molecular markers are well-established in all phases of osseointegration following DIP, there is no available literature comparing differences in biomarkers during healing periods between IIP and DIP. Conclusions: This review highlights the similarities and differences in the outcomes of IIP and DIP, as well as the knowledge gaps that require further investigation, providing valuable insights for predicting treatment outcomes and managing complications associated with dental implant placement.

Heterotopic ossification (HO) is prevalent following orthopedic trauma, traumatic brain and spinal cord injuries, brain, and limb amputations, particularly in combat veterans. HO causes pain, limited mobility and decreased quality of life. Current treatments are limited and have significant complications with high recurrence rates, underscoring the need for improved therapeutic interventions. In this study, we used genetically engineered osteoclasts (OCs) as a cell therapy to treat HO. Inducible, engineered myeloid precursors (iRANK cells) treated with chemical inducer of dimerization (CID) differentiated into TRAP+ multinucleated OCs, expressed functional osteopontin, and resorbed mineralized tissues in vitro. To investigate if iRANK OCs could reduce HO in vivo, HO lesions were induced by injections of BMP-2, and iRANK cells were locally delivered to ectopic bone nodules with concomitant systemic administration of CID. Micro-CT and histology showed that HO lesions were significantly reduced, and more OCs were observed in the cell-treated group compared to the control. Moreover, many OCs were TRAP, MMP9, and GFP-positive indicating that they differentiated from delivered iRANK cells. Thus, our data confirm the ability of engineered myeloid precursors to differentiate into OCs and resorb HO lesions in vivo paving the way for OC delivery as a promising approach for HO treatment.